CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MediGene AG Company Snapshot
MediGene AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other miscellaneous service companies in Europe: Genoway of France (2017 sales of 9.86 million Euro [US$11.54 million] ), GW Pharmaceuticals PLC of the United Kingdom (£8.24 million [US$11.00 million] of which 94% was Commercial), and Thrombogenics Nv which is based in Belgium (9.06 million Euro [US$10.59 million] ).

Sales Analysis. MediGene AG reported sales of 10.30 million Euro (US$12.04 million) for the year ending December of 2017. This represents an increase of 39.4% versus 2016, when the company's sales were 7.38 million Euro. Sales of Immunotherapies saw an increase that was more than double the company's growth rate: sales were up 364.0% in 2017, from 1.05 million Euro to 4.89 million Euro. Not all segments of MediGene AG experienced an increase in sales in 2017: sales of Outlincencedproducts fell 54.5% to 2.79 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
MediGene AG
  Stock Performance Chart for MediGene AG
 
  Stock Data: Recent Stock Performance:
  Current Price (5/25/2018): 14.29
(Figures in Euro)
1 Week -12.3%   13 Weeks 2.9%  
4 Weeks -20.6%   52 Weeks 30.1%  
 
MediGene AG Key Data:
  Ticker: MDG1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 10,295,000
(Year Ending Jan 2018).
Employees: 96
  Currency: Euro Market Cap: 318,826,005
  Fiscal Yr Ends: December Shares Outstanding: 22,311,127
  Share Type: Namenaktie Closely Held Shares: 929,368
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.